Polymyalgia rheumatica

PMR · Immunology · 1 drugs · 1 indications

Competitive Landscape (1 drugs)
DrugCompanyMechanismModalityRouteStage
CosentyxNVSIL-17A inhibitorAntibodySCAPPROVED
Indications (1)
Polymyalgia rheumatica
Cosentyx PHASE3
Upcoming Catalysts
Cosentyx - Biosimilar Competition TimelineCOMPETITIVE
NVSOngoing
Data from Supabase · Updated 2026-03-24